Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA03 - Clinomics and Genomics
- 10:30 - 12:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Heather A Wakelee, Wilfried Ernst Erich Eberhardt
-
+
MA03.01 - The Impact of Early Steroids on Clinical Outcomes in Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors- A Cancerlinq Cohort
10:30 - 10:35 | Presenter: Nathan Pennell | Author(s): Pradnya Dinkar Patil, Xuefei Jia, Brian Hobbs
- Abstract
Loading... -
+
MA03.02 - Genetic Variants in ERAP1 and NCF2 in the MHC Class I Related Genes Are Associated with Non-Small Cell Lung Cancer Survival
10:35 - 10:40 | Presenter: Sen Yang | Author(s): Qingyi Wei, David C Christiani, Qiming Wang
- Abstract
Loading... -
+
MA03.03 - CEA and CYFRA 21-1 as Prognostic Biomarkers of Benefit from Nivolumab and as a Tool in Treatment Monitoring in Advanced NSCLC
10:40 - 10:45 | Presenter: Filippo Gustavo Dall'Olio | Author(s): Francesca Abbati, Francesco Facchinetti, Francesco Gelsomino, Barbara Melotti, Maria Massucci, Sebastiano Buti, Michele Veneziani, marcello Tiseo, Andrea Ardizzoni
- Abstract
Loading... -
+
MA03.04 - Discussant - MA03.01, MA03.02, MA03.03
10:45 - 11:00 | Presenter: Nathan Pennell
- Abstract
No abstract available for this presentation
-
+
MA03.05 - BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
11:00 - 11:05 | Presenter: Marcelo Vailati Negrao | Author(s): Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bara, Vincent Shen, Sylvia Hu, Yasir Elamin, Xiuning Le, Michael E Goldberg, Chang-Jiun Wu, Jianhua Zhang, David S Barreto, Waree Rinsurongkawong, George R Simon, Jack Roth, Stephen Swisher, Jack Lee, Anne Tsao, Vassiliki A Papadimitrakopoulou, Don Lynn Gibbons, Bonnie Glisson, Vincent A Miller, Brian Alexander, Garrett M Frampton, Lee A Albacker, David S Shames, Jianjun Zhang, John Victor Heymach
- Abstract
Loading... -
+
MA03.06 - Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC
11:05 - 11:10 | Presenter: Enriqueta Felip | Author(s): Paal Brunsvig, Åslaug Helland, Nuria Viñolas, Santiago Ponce Aix, Enric Carcereny, Manuel Dómine, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J. Holt, Dominic Smethurst, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Julia Schoelermann, Katherine Lorens, Emmett V. Schmidt, Michael Jon Chisamore, Matthew Krebs
- Abstract
Loading... -
+
MA03.07 - First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations
11:10 - 11:15 | Presenter: Kyaw Zin Thein | Author(s): Nusrat Jahan, Aung Myint Tun, Anita Sultan, Sriman Swarup, Francis Mogollon-Duffo, Rachana Yendala, Miguel Quirch, Thura Win Htut, Nicholas D’cunha, Shabnam Rehman, Fred Hardwicke, Sanjay Awasthi, Lukman Tijani
- Abstract
Loading... -
+
MA03.08 - Discussant - MA03.05. MA03.06, MA03.07
11:15 - 11:30 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
MA03.09 - Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers
11:30 - 11:35 | Presenter: Marie Mayenga | Author(s): Isabelle Monnet, Marie-Ange Massiani, Jean-Baptiste Assié, Laure Tabeze, Sylvie Friard, Severine Fraboulet, Anne-Cécile Metivier, Christos Chouaid, Leila Zemoura, Elisabeth Longchampt, Samia Melaabi, Louis-Jean Couderc, Helene Doubre
- Abstract
Loading... -
+
MA03.10 - Prospective Evaluation of a Prognostic Clinico-Molecular Score (DEMo) to Predict Outcome of Advanced NSCLC Patients Treated with Immunotherapy
11:35 - 11:40 | Presenter: Arsela Prelaj | Author(s): Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Roberto Ferrara, Mavis Mensah, Giulia Galli, Alessandro De Toma, Giovanni Randon, Filippo Pagani, MARTA Brambilla, Benedetta Trevisan, Monica Ganzinelli, Nicoletta Zilembo, Filippo Guglielmo Maria De Braud, VALTER Torri, Marina Chiara Garassino, Gabriella Sozzi, Mattia Boeri
- Abstract
Loading... -
+
MA03.11 - Chemotherapy After PD-1 Inhibitors Versus Chemotherapy Alone in Patients with Non–Small Cell Lung Cancer (WJOG10217L)
11:40 - 11:45 | Presenter: Hirotsugu Kenmotsu | Author(s): Eriko Miyawaki, Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, Junichi Shimizu, Tomohiro Ozaki, Daichi Fujimoto, Ryo Toyozawa, Yuki Akazawa, Motoyasu Okuno, Sayako Morikawa, Tatsuo Ohira, Taishi Harada, Ryota Ushio, Akihito Kubo, Toshiyuki Harada, Nozomu Kimura, Hiroyuki Yamaguchi, Kazuo Nishikawa, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading... -
+
MA03.12 - Discussant - MA03.09, MA03.10, MA03.11
11:45 - 12:00 | Presenter: HOWARD WEST
- Abstract
No abstract available for this presentation
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-27 - Processing Escapes: Novel Resistance Mechanisms Under Immune Checkpoint Inhibition in NSCLC
09:45 - 09:45 | Presenter: Michael Wessolly | Author(s): Anna Streubel, Robert Werner, Sabrina Borchert, Susann Stephan-Falkenau, Sergej Griff, Elena Mairinger, Jan Schmeller, Robert Fred Henry Walter, Torsten Bauer, Wilfried Ernst Erich Eberhardt, Torsten Gerriet Blum, Kurt Werner Schmid, Jens Kollmeier, Fabian Dominik Mairinger, Thomas Mairinger
- Abstract
Loading...
-
+
P1.06 - Mesothelioma
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Mesothelioma
-
+
P1.06-12 - Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma
09:45 - 09:45 | Presenter: Sabrina Borchert | Author(s): Michael Wessolly, Jan Schmeller, Elena Mairinger, Jens Kollmeier, Thomas Hager, Thomas Mairinger, Thomas Herold, Daniel Christian Christoph, Robert Fred Henry Walter, Wilfried Ernst Erich Eberhardt, Till Plönes, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Fabian Dominik Mairinger
- Abstract
Loading...
-
+
IS15 - Symposium by Medscape: Immune Checkpoint Inhibitor Treatment for Frontline Metastatic NSCLC: The Evolving Role of Biomarkers in Guiding Decisions
- 18:15 - 19:45
- 9/09/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
ES23 - Optimal Management of N2 Disease in the Era Of IO
- 11:30 - 13:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Alex Martinez-Marti, Hong-Xu Liu
-
+
ES23.03 - Is CT/RT Followed by I/O the Standard of Care for All N2 and Selected N3 Patients?
12:00 - 12:15 | Presenter: Wilfried Ernst Erich Eberhardt
- Abstract
Loading...
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading...